SCHEMBL31268908

SCHEMBL31268908

Cc1ccnc(Cn2c(-c3ccc(OCCNS(C)(=O)=O)cc3Cl)nc3c(OC4(C)CC4)ncnc32)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNJ5 P48544 1/20 0.33
▸ KCNJ3 P48549 1/20 0.33
▸ DYRK3 O43781 1/20 0.33
▸ ROCK2 O75116 1/20 0.33
▸ PRKD3 O94806 1/20 0.33
▸ MAP4K4 O95819 1/20 0.33
▸ CDK1 P06493 1/20 0.33
▸ ROS1 P08922 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ PRKACA P17612 1/20 0.33
▸ RPS6KB1 P23443 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ AKT1 P31749 1/20 0.33
▸ CLK2 P49760 1/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ IRAK1 P51617 1/20 0.33
▸ RPS6KA3 P51812 1/20 0.33
▸ PRKX P51817 1/20 0.33
▸ CDK5 Q00535 1/20 0.33
▸ PRKCD Q05655 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31269038 0.91 PIK3CD (0.32) PIK3CD
SCHEMBL31268874 0.90 KDM4E (0.32) PIK3CD
SCHEMBL31269169 0.90 PIK3CD (0.32) PIK3CD
SCHEMBL31269111 0.90 HRH4 (0.32) PIK3CD
SCHEMBL31269106 0.89 INSR (0.32) GSK3BCNR1CNR2PIK3CDALK
SCHEMBL31269059 0.89 PIK3CD (0.34) CNR1CNR2PIK3CDALK
SCHEMBL31268953 0.88 PDK2 (0.33) DYRK1ACNR1CNR2PIK3CD
SCHEMBL31268950 0.87 KCNH2 (0.32) PIK3CD
SCHEMBL30984004 0.87 KCNH2 (0.32) PIK3CD
SCHEMBL30983456 0.87 PIK3CD (0.35) PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback